Carole Ho
2021
In 2021, Carole Ho earned a total compensation of $6.5M as Chief Medical Officer at Denali Therapeutics, a 51% increase compared to previous year.
Compensation breakdown
| Bonus | $284,170 |
|---|---|
| Option Awards | $3,648,420 |
| Salary | $473,616 |
| Stock Awards | $2,125,800 |
| Other | $11,600 |
| Total | $6,543,606 |
Ho received $3.6M in option awards, accounting for 56% of the total pay in 2021.
Ho also received $284.2K in bonus, $473.6K in salary, $2.1M in stock awards and $11.6K in other compensation.
Rankings
In 2021, Carole Ho's compensation ranked 1,904th out of 12,415 executives tracked by ExecPay. In other words, Ho earned more than 84.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,904 out of 12,415 | 85th |
Division Manufacturing | 716 out of 5,505 | 87th |
Major group Chemicals And Allied Products | 271 out of 2,375 | 89th |
Industry group Drugs | 231 out of 2,096 | 89th |
Industry Biological Products, Except Diagnostic Substances | 67 out of 449 | 85th |
Source: SEC filing on April 19, 2022.
Ho's colleagues
We found three more compensation records of executives who worked with Carole Ho at Denali Therapeutics in 2021.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019